title: Drugs that lack single-agent activity: are they worth pursuing in combination?
authors.affiliation: Department of Haemato-Oncology, Nobel Hospital, Sinamangal, Kathmandu 21034, Nepal.
authors.forename: Bishal
authors.initials: B
authors.lastname: Gyawali
authors.affiliation: Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Sciences University (OHSU), 3181 South West Sam Jackson Park Road, Portland, Oregon 97239-3098, USA.|Department of Public Health and Preventive Medicine, OSHU, 3181 South West Sam Jackson Park Road, Portland, Oregon 97239-3098, USA.|Center for Ethics in Health Care, OHSU, 3181 South West Sam Jackson Park Road, Portland, Oregon 97239-3098, USA.
authors.forename: Vinay
authors.initials: V
authors.lastname: Prasad
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D010166:Palliative Care